The development and application of NRICM101 and NRICM102 for the treatment of COVID-19
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-07-01
|
Series: | Journal of the Formosan Medical Association |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0929664623001419 |
_version_ | 1827933010479022080 |
---|---|
author | Shung-Tai Ho Yun-Ning Tsai Yi-Chang Su |
author_facet | Shung-Tai Ho Yun-Ning Tsai Yi-Chang Su |
author_sort | Shung-Tai Ho |
collection | DOAJ |
first_indexed | 2024-03-13T07:18:38Z |
format | Article |
id | doaj.art-f63c6acf27ce45c78da817d0d765f058 |
institution | Directory Open Access Journal |
issn | 0929-6646 |
language | English |
last_indexed | 2024-03-13T07:18:38Z |
publishDate | 2023-07-01 |
publisher | Elsevier |
record_format | Article |
series | Journal of the Formosan Medical Association |
spelling | doaj.art-f63c6acf27ce45c78da817d0d765f0582023-06-05T04:12:27ZengElsevierJournal of the Formosan Medical Association0929-66462023-07-011227525527The development and application of NRICM101 and NRICM102 for the treatment of COVID-19Shung-Tai Ho0Yun-Ning Tsai1Yi-Chang Su2Chinese Medical Advancement Foundation, Taichung 403, Taiwan; Department of Anesthesiology, National Defense Medical Center, Taipei 114, Taiwan; Department of Anesthesiology, Kaohsiung Medical University Hospital, Kaohsiung 807, TaiwanChinese Medical Advancement Foundation, Taichung 403, Taiwan; Department of Chinese Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, TaiwanChinese Medical Advancement Foundation, Taichung 403, Taiwan; National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei 112, Taiwan; Corresponding author. No. 155-1, Sec. Linong St., Beitou Dist., Taipei City 112304, Taiwan. Fax: +886 2 2825 0743.http://www.sciencedirect.com/science/article/pii/S0929664623001419 |
spellingShingle | Shung-Tai Ho Yun-Ning Tsai Yi-Chang Su The development and application of NRICM101 and NRICM102 for the treatment of COVID-19 Journal of the Formosan Medical Association |
title | The development and application of NRICM101 and NRICM102 for the treatment of COVID-19 |
title_full | The development and application of NRICM101 and NRICM102 for the treatment of COVID-19 |
title_fullStr | The development and application of NRICM101 and NRICM102 for the treatment of COVID-19 |
title_full_unstemmed | The development and application of NRICM101 and NRICM102 for the treatment of COVID-19 |
title_short | The development and application of NRICM101 and NRICM102 for the treatment of COVID-19 |
title_sort | development and application of nricm101 and nricm102 for the treatment of covid 19 |
url | http://www.sciencedirect.com/science/article/pii/S0929664623001419 |
work_keys_str_mv | AT shungtaiho thedevelopmentandapplicationofnricm101andnricm102forthetreatmentofcovid19 AT yunningtsai thedevelopmentandapplicationofnricm101andnricm102forthetreatmentofcovid19 AT yichangsu thedevelopmentandapplicationofnricm101andnricm102forthetreatmentofcovid19 AT shungtaiho developmentandapplicationofnricm101andnricm102forthetreatmentofcovid19 AT yunningtsai developmentandapplicationofnricm101andnricm102forthetreatmentofcovid19 AT yichangsu developmentandapplicationofnricm101andnricm102forthetreatmentofcovid19 |